‘So ... can I get this peptide?’: the loophole making way for the US’s ‘wild west’ of untested drugs
Summary
A panel within the Food and Drug Administration (FDA), influenced by Robert F. Kennedy Jr.'s advocacy, recommended allowing certain peptides to be sold legally in the US without full safety and effectiveness tests. They plan to use a regulatory loophole involving compounding pharmacies, which are less regulated and can provide these untested peptides to consumers.Key Facts
- Robert F. Kennedy Jr. spoke about peptides on Joe Rogan’s podcast in early 2026.
- Peptides like BPC-157 and TB-500 are popular in wellness communities but lack FDA approval for regular use.
- The Biden-era FDA halted many peptides due to safety and effectiveness concerns.
- Kennedy pushed for making peptides easier to obtain legally.
- An FDA advisory committee recommended reclassifying six out of seven peptides to allow legal sales.
- This recommendation uses compounding pharmacies, which can produce drugs without full FDA oversight.
- Compounding pharmacies traditionally make custom medications but have sometimes caused safety issues.
- The new policy could lead to wider access to untested peptides in the US market.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
